Immunogenicity and safety of different platforms of COVID-19 vaccines given as a third (booster) dose in healthy adults.

Lin, Zemin; Cheng, Mengnan; Zhu, Fenghua; Yang, Xiaoqian; Zuo, Jianping; He, Shijun

Lin, Zemin; Cheng, Mengnan; Zhu, Fenghua; Yang, Xiaoqian; Zuo, Jianping; He, Shijun.

Lin Z; Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Cheng M; Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Zhu F; Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yang X; Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Zuo J; Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
He S; University of Chinese Academy of Sciences, Beijing, China.

J Med Virol ; 94(9): 4047-4052, 2022 09.

Article in English | MEDLINE | ID: covidwho-1866546

Subject(s)

COVID-19 Vaccines; COVID-19; Adult; Antibodies, Viral; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Adult / Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27836

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google